697762-67-7

Basic information

• Product Name: Methyl 2-chloro-3-methoxy-5-bromobenzoate
• Synonyms: Methyl 2-chloro-3-methoxy-5-bromobenzoate;Methyl 5-bromo-2-chloro-3-methoxybenzoate
• CAS NO: 697762-67-7
• Molecular Formula: C₉H₈BrClO₃
• Molecular Weight: 279.51502
• Mol File: 697762-67-7.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 314.5±37.0 °C(Predicted)
• Appearance: /
• Density: 1.557±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Methyl 2-chloro-3-methoxy-5-bromobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-chloro-3-methoxy-5-bromobenzoate(697762-67-7)
• EPA Substance Registry System: Methyl 2-chloro-3-methoxy-5-bromobenzoate(697762-67-7)

Safety Data

• Hazardous Substances Data: 697762-67-7(Hazardous Substances Data)

Usage

General Description

Methyl 2-chloro-3-methoxy-5-bromobenzoate is an organic compound with the chemical formula C9H8BrClO3. It is a member of the benzoate ester family and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. The compound is a white, crystalline solid with a molecular weight of 271.51 g/mol. It is known to be a potential irritant to the eyes, skin, and respiratory system, and should be handled with care. Methyl 2-chloro-3-methoxy-5-bromobenzoate is not considered to be environmentally hazardous, but proper disposal methods should still be followed to prevent any negative impact on the environment.

Upstream product

• 5121-34-6 methyl 2-amino-3-methoxybenzoate 
• 4920-80-3 3-methoxy-2-nitrobenzoic acid 
• 5307-17-5 methyl 3-methoxy-2-nitrobenzoate 
• 115378-21-7 methyl 2-amino-5-bromo-3-methoxy-benzoate 

Downstream Products

• 697762-68-8 5-bromo-2-chloro-3-hydroxybenzoic acid 
• 1415470-79-9 (2S,3R,4R,5S,6R)-2-(6-(4-ethylbenzyl)-7-chloro-2,3-dihydrobenzofuran-4-yl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol 
• 1415470-82-4 (2S,3R,4R,5S,6R)-2-(8-chloro-7-(4-ethylbenzyl)chroman-5-yl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1415470-83-5 (2S,3R,4R,5S,6R)-2-(7-chloro-6-(4-ethoxybenzyl)-2,3-dihydrobenzofuran-4-yl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol 
• 1415467-76-3 5-bromo-2-chloro-3-methoxybenzoic acid 

Relevant articles and documents

Discovery of GCC5694A: A potent and selective sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes

Sodium-dependent glucose co-transporter 2 (SGLT2) has emerged as a promising drug target for the treatment of type 2 diabetes, and recently, several SGLT2 inhibitors have been approved for clinical use. A series of molecules with a C-aryl glucoside scaffo

NOVEL 2-AMINO-PYRIDINE AND 2-AMINO-PYRIMIDINE DERIVATIVES AND MEDICINAL USE THEREOF

Provided is a compound superior in an autotaxin inhibitory action and the like, effective as a prophylactic or therapeutic drug for diseases involving ATX. The present invention relates to a compound represented by the following formula (I): [wherein each symbol is as described in the DESCRIPTION], which has a superior autotaxin inhibitory action and is useful as a prophylactic or therapeutic drug for diseases involving ATX.

NOVEL 4-OXOQUINOLINE COMPOUND AND USE THEREOF AS HIV INTEGRASE INHIBITOR

Provision of a compound having an anti-HIV activity, particularly an integrase inhibitory activity.A 4-oxoquinoline compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof: wherein each symbol is as defined in the specification.The present invention also relates to a pharmaceutical composition containing the 4-oxoquinoline compound or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier; an integrase inhibitor, an antiviral agent, anti-HIV agent and the like, which contains the 4-oxoquinoline compound or a pharmaceutically acceptable salt thereof as an active ingredient; an anti-HIV composition containing the 4-oxoquinoline compound or a pharmaceutically acceptable salt thereof, and one or more other kinds of anti-HIV activity substances as active ingredients; an anti-HIV agent containing the 4-oxoquinoline compound or a pharmaceutically acceptable salt thereof as an active ingredient, which is used for a multiple drug therapy with other anti-HIV agent(s), and the like.